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Abstract
Paratuberculosis vaccination in cattle has been restricted due to its possible interference
with the official diagnostic methods used in tuberculosis eradication programs. To overcome
this drawback, new possibilities to detect Mycobacterium bovis infected cattle in paratuber-
culosis vaccinated animals were studied under experimental conditions. Three groups of 5
calves each were included in the experiment: one paratuberculosis vaccinated group, one
paratuberculosis vaccinated and M. bovis infected group and one M. bovis infected group.
The performance of the IFN-gamma release assay (IGRA) and the skin test using conven-
tional avian and bovine tuberculins (A- and B-PPD) but also other more specific antigens
(ESAT-6/CFP10 and Rv3615c) was studied under official and new diagnostic criteria.
Regarding the IGRA of vaccinated groups, when A- and B-PPD were used the sensitivity
reached 100% at the first post-challenge sampling, dropping down to 40–80% in subse-
quent samplings. The sensitivity for the specific antigens was 80–100% and the specificity
was also improved. After adapting the diagnostic criteria for the conventional antigens in the
skin test, the ability to differentiate between M. bovis infected and non-infected animals
included in paratuberculosis vaccinated groups was enhanced. Taking for positive a relative
skin thickness increase of at least 100%, the single intradermal test specificity and sensitiv-
ity yielded 100%. The comparative intradermal test was equally accurate considering a B-
PPD relative skin increase of at least 100% and greater than or equal to that produced by A-
PPD. Using the specific antigens as a proteic cocktail, the specificity and sensitivity reached
100% considering the new relative and absolute cut-offs in all experimental groups (Δ30%
and Δmm 2, respectively). Results suggest that the interference caused by paratuberculo-
sis vaccination in cattle could be completely overcome by applying new approaches to the
official tuberculosis diagnostic tests.
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Introduction
Bovine tuberculosis (bTB) and paratuberculosis (PTB) are widespread infectious diseases that
affect many domestic [1,2] and wild [3,4] species. The impact of these diseases derives from
losses to the livestock industry, especially dairy cattle [5,6], from hunting and wildlife conser-
vation as well as from their recognized (bTB) or suspected (PTB) zoonotic character. The rele-
vance of bTB as a zoonosis has been substantially reduced in the more developed countries,
but it is still a frequent cause of morbidity and mortality in countries that cannot afford strong
control measures like milk thermal treatment and compulsory bTB eradication schedules [6].
It has been estimated that about 10% of the total human tuberculosis cases around the world
are caused by Mycobacterium bovis (M. bovis) [7,8]. On the other hand Mycobacterium avium
subsp. paratuberculosis (Map) is considered potentially zoonotic since it was first isolated from
human patients in 1984 [9] and has also been firmly associated with some forms of chronic
regional intestinal inflammatory disease [10–12], although an etiological role has not been
widely accepted by the medical community.
The live M. bovis Bacillus Calmette-Guerin (BCG) has been used as a vaccine in humans [6]
as well as in cattle [13], showing different levels of protection against M. bovis infection. One of
the major disadvantages of the use of this attenuated vaccine in cattle is the interference with
bTB diagnostic tools due to cross reactivity of the tuberculins with antigens of the vaccine itself.
PTB is considered one of the most important diseases in dairy cattle, decreasing the milk
production by up to 10% [5,14]. It has been proven that PTB vaccination in sheep and goats
with Map whole heat-inactivated vaccines efficiently prevents the disease and significantly
diminishes the bacterial burden reducing the chance for other animals of becoming infected
[15]. As a consequence PTB vaccination should be taken into account in countries where bTB
prevalence is really low and the Animal Health System works efficiently [16].
In Spain, PTB vaccination is not allowed in cattle due to the possible interference in the offi-
cial immunological bTB diagnostic tests [17]. bTB herd prevalence in Spain is 1.2% [18] but
the Basque Country is one of the regions with lowest frequencies (0.25%) [19] and it can be
very closely monitored thanks to its small size and well developed veterinarian services. For
these reasons a field clinical trial for an inactivated vaccine registration was authorized by the
competent authorities (local Animal Health and Animal Experimentation Authority, the Span-
ish Drug Registration Authority and the Central Animal Health Authority) whose results have
been partially published [16,17,20]
Moreover, simultaneous infection of herds with Map and M. bovis may occur [21] and it
may be responsible for a reduced sensitivity (Se) of the cell-mediated immune (CMI)
response-based tests to detect bTB [22]. Over the last few years, antigens that are present in M.
bovis but absent in both: tuberculosis (BCG) and PTB vaccines, such as ESAT-6/CFP-10 or
Rv3615c, have been assayed as an alternative to avian and bovine purified protein derivatives
(A-PPD and B-PPD), traditionally used in the current Comparative Intradermal Test (CIT)
and interferon (IFN)-gamma assays [23].
Another issue that may affect bTB diagnosis is exposure to environmental mycobacteria,
especially Mycobacterium avium avium (M. a. avium). Previous studies have concluded that
exposure to M. a. avium may impart a degree of immunity to M. bovis infection that can com-
promise currently used diagnostic tests, making improvement of test Se dependent on the use
of specific antigens [24]. Regarding vaccine protection, some authors have concluded that sen-
sitization with environmental mycobacteria may adversely affect the efficacy of the BCG vacci-
nation [25] whereas others suggest that there is no evidence that natural pre-exposure to M.
avium reduces the effectiveness of BCG vaccination [26] and that it rather causes an overall
protection that cannot be further increased by vaccination.
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The goal of this work was to assess different strategies to avoid PTB vaccination interference
with CMI response-based bTB detection tests in cattle experimentally challenged by the use of
both: alternative interpretation criteria for the standard comparative intradermal test and new
more specific antigens [24].
Materials and Methods
Calves, inclusion criteria and vaccination
The experimental scheme is detailed on Fig 1. Thirty Fresian calves from a feedlot were prese-
lected to carry out this experiment. These animals were born in 13 different farms located in
Northern Spain. Two months after birth, at week 0 (W0), animals were submitted to a IFN-
gamma release assay with standard (A-PPD, B-PPD) or more specific (ESAT-6/CFP10 and
Rv3615c) antigens for the diagnosis of bTB. Immediately afterwards, 20 of them were subcuta-
neously vaccinated against Map with 1ml of a heat inactivated vaccine (Silirum1 CZV, Por-
riño, Pontevedra, Spain) in the dewlap [17]. To confirm absence of contact with M. bovis, the
samplings were repeated twice (W4, W12). Only 15 animals: 10 vaccinated and 5 non-vacci-
nated were kept and transferred to the biosafety level 3 (BSL-3) facilities in NEIKER. After
arrival, calves were split into three separate groups of five animals each. The 15 remaining
calves were kept in the feedlot and not further followed.
M. bovis challenge
All the experimental procedures were carried out according to the European, National and
Regional Law and Ethics Committee regulations. The experimental design underwent ethical
review and approval by NEIKER’s Animal Care and Use Committee and by the Agriculture
Department (PARAPATO-1264-BFA). Once animals were transferred to the BSL-3 facilities,
they went through a two-week adaptation period. At W18 animals were sampled and five vac-
cinated and five non-vaccinated animals were challenged with 106 colony forming units
(CFU) of an M. bovis field isolate suspended in 2 ml of phosphate-buffered saline (PBS) by the
endotracheal route. The isolate used for challenge was originally obtained from a naturally
infected cow and identified as M. bovis spoligotype profile SB0339 according to the M.bovis
Spoligotype Database website (www.mbovis.org). Prior to challenge, animals underwent intra-
muscular sedation with Xylazine (10 mg/50 kg). The final experimental groups were: PTB vac-
cinated and M. bovis infected (VAC/INFEC), PTB vaccinated and M. bovis non-infected
(VAC/NIN), and PTB non vaccinated and M. bovis infected (NVAC/INFEC).
Fig 1. Experimental scheme. VAC/INFEC: vaccinated infected group. VAC/NIN: vaccinated non-infected
group. NVAC/INFEC: non-vaccinated infected group BS: Blood Sampling. S: Slaughter. P+B: Pathology and
Bacteriology. CIT: Comparative Intradermal Test. W: Week.
doi:10.1371/journal.pone.0169735.g001
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Blood sampling
Blood was collected from the jugular or caudal vein at W0, W4, W12, W18, W20, W22, W26
and W30 in tubes with lithium heparin and immediately aliquoted and processed in the
laboratory.
Diagnostic tests
IFN-gamma release assay. Stimulation of whole blood with B-PPD, A-PPD and defined
antigens, ESAT-6/CFP-10 and Rv3615, was carried out within 8 hours after sample collec-
tion. Five 1.5 ml aliquots of whole blood from each animal were stimulated with: 100 μl of
PBS, 100 μl of A- and B-PPD(20μg/ml as assay concentration) (CZV, Porriño, Pontevedra,
Spain) respectively, and with 150 μl (to achieve an assay concentration of 5 μg/ml each
peptide) of ESAT-6/CFP10 and Rv3615c antigens that were tested as sets of overlapping
peptides representing either ESAT-6/CFP-10 in one peptide cocktail or, alternatively, a pep-
tide cocktail representing Rv3615c [27]. After incubating the plates for 16-24h at 37˚C
5–7%CO2 the stimulated samples were centrifuged and subsequently the plasma was
separated.
Quantification of IFN-gamma concentration in the plasma’s supernatant was performed by
ELISA using the Bovigam1 commercial kit according to the manufacturer’s instructions
(Prionics, Schlieren, Switzerland).
For result analysis, our first approach was to represent mean optical density (OD) values for
each antigen to compare the treatment groups. The OD of the non-stimulated samples was
subtracted from the OD of those stimulated with the different antigens. Afterwards, OD cut-
offs were established for each defined M. bovis antigen, and frequencies of positive results were
calculated and compared among groups.
Cut-offs alternative to the currently established ones for the standard antigens were studied
for this experiment. Also, considering that our group of interest was the VAC/NIN, a new cut-
off for the specific antigen (ESAT-6/CFP10) different from the previously defined cut-off by
Vordermeier et al. [28], was selected. The goal was to find cut-offs that would allow us to
improve and maximize both: Se and Sp of the diagnostic techniques. This approach which will
be thoroughly explained in the results section.
Comparative intradermal test (CIT). The CIT was carried out at W3, this is, one week
before slaughter. The test was performed according to the European Communities Commis-
sion Regulations (regulation1226/2002, amending annexes A and B of the consolidated Coun-
cil Directive 64/432/EEC) and the Royal Decree RD2611/1996 by the Official Veterinary
Services inoculating 0.1 ml of B-PPD and A-PPD. In addition to the standard PPD antigens,
0.1 ml of a peptide cocktail (100 μg/ml/peptide) and a protein cocktail (100 μg/ml/protein)
representing ESAT-6/CFP10 and Rv3615c were also used. Four sites on the necks of the ani-
mals were selected and the skin thickness of every injection site was measured before and 72 h
after the inoculation. The interpretation was carried out according to official criteria (EU
Council Directive 64/432/CEE and RD 2611/1996).
Since standard criteria showed lower Se or Sp in vaccinated animals, alternative criteria
were studied for skin test interpretation in the different tests regarding not only the absolute
but also the relative skin thickness increase threshold and antigen comparison. The obtained
outcomes are shown in the result section.
Post-mortem studies. The animals were slaughtered at W32 in three consecutive days,
five calves per day. The animals underwent sedation with XILAGESIC1 2% (10 mg/ 50 kg l.w)
(Laboratorios Calier, S.A., Barcelona, Spain) and then euthanized by an intravenous injection
of T61 (4-6ml/50kg). Complete necropsies were carried out and samples were collected from
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several organs (lymph nodes, lung, tonsils, liver and kidney) for histopathological and micro-
biological analysis.
Data analysis. Frequency of positive results in each group/technique/antigen and time
was used as a qualitative variable for diagnostic time dynamics description and group Se and
Sp estimates comparison.
Results
Success of challenge procedure
Infection was achieved in all challenged animals as all were confirmed infected by bacteriologi-
cal and pathological analysis. VAC/NIN animals did not present lesions compatible with bTB,
whereas all the animals belonging to the challenged groups did. All isolates displayed the same
M. bovis spoligotype as the challenge strain. Post-mortem findings will be reported elsewhere.
IFN-gamma. The mean value for every IFN-gamma result obtained was calculated. If the
outcome for the B-PPD was 0.1 and B-PPD>A-PPD or Rv3615c was 0.1 or 0.3 for
ESAT-6/CFP10 the results were considered M. bovis positive, respectively.
Evolution of average IFN-gamma release over time per group and antigen is shown on Fig
2. The IFN-gamma levels upon stimulation with standard antigens A-PPD and B-PPD (Fig
2A, 2B and 2C) showed slight response increase in both vaccinated groups (VAC/NIN and
VAC/INFEC) at W12, whereas the NVAC/INFEC group did not respond to standard antigens
during the pre-infection period. However, upon challenge, reactions against A-PPD and
B-PPD rose in all three groups of animals. The VAC/NIN (Fig 2A) group showed a heteroge-
neous response with peaks and troughs from W18 to W26, always higher to the A-PPD than to
the B-PPD and declining sharply in both cases after W26. On the contrary, the NVAC/INFEC
group (Fig 2C) showed an increasing response following B-PPD stimulation throughout the
post-infection period.
The response to the defined antigens showed higher definition than the standard ones as
seen in Fig 2D, 2E and 2F. During the pre-challenge period none of the animals in any of the
groups showed any kind of response against ESAT-6/CFP10 or Rv3615c. However, infection
immediately triggered a response in both infected groups (VAC/INFEC and NVAC/INFEC)
(Fig 2E and 2F) although the NVAC/INFEC animals (Fig 2F) showed slightly higher IFN-
Fig 2. Cellular immune response measured as IFN-gamma release. Avian-PPD (gray rhombus), Bovine-
PPD (black square) (A, B, C), ESAT-6/CFP10 (black square) and Rv3615c (gray rhombus) (D, E, F). Groups:
vaccinated non-infected (VAC/NIN) (A and D), vaccinated infected (VAC/INFEC) (B and E) and non-
vaccinated infected (NVAC/INFEC) (C and F).
doi:10.1371/journal.pone.0169735.g002
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gamma levels compared to the VAC/INFEC animals (Fig 2E). Surprisingly, the VAC/NIN
group (Fig 2D) showed a minimum response at W22. ESAT-6/CFP10 showed higher discrimi-
nation power since differences between infected and non-infected groups were greater.
The qualitative results for the IFN-gamma release test are shown on Table 1. The B-PPD
detected all infected animals in the NVAC/INFEC during the post-infection period, showing
different degrees of detection in the VAC/INFEC group and slight cross reactivity in some of
the VAC/NIN animals. Applying the calculated cut-offs for the defined M. bovis antigens, in
the VAC/NIN group a slight non-specific reaction could be observed for both during the post-
infection weeks although infection was discarded according to histopathological and microbi-
ological results. This behavior tended to disappear in the last sampling at W30. These defined
specific antigens exhibited a mild delay in the detection of infected animals in the VAC/
INFEC group. Regarding Rv3615c, the reactivity seemed to decrease at W30. Both, Rv3615c
and ESAT-6/CFP10 peptide cocktails were equally efficient at classifying animals from the
NVAC/INFEC group from W22 on.
Comparative Intradermal Test (CIT). Skin test raw data and interpretation are detailed
on Table 2. All calves included in the VAC/NIN group (5/5) showed a PPD-A response bias
and were therefore classified as CIT-negative. However, substantial responses were recorded
to PPD-B which meant that 3/5 calves were classified as SIT-positive (Table 2).
The skin test was performed using two more antigenic preparations: ESAT-6/CFP10-Rv3615c
as a peptide or protein cocktail. We considered a skin increase of 2 mm or greater as a posi-
tive result. Using this cut-off value, 1/5 VAC/NIN animals tested positive to the ESAT-6/
CFP10-Rv3615c peptide cocktail while none responded to the protein cocktail (0/5, Table 2).
Taken together, while the Sp of the SIT is compromised by PTB vaccination, this limitation
can be overcome by using the CIT or defined protein antigens as skin test reagent.
Following M. bovis infection, the detection (Se) of infection in the PTB vaccinated group
(VAC/INFEC) was severely compromised as 3/5 animals escaped CIT detection due to the
PPD-A biased responses (Table 2) as well as in the non-vaccinated/infected group (NVAC/
INFEC) were an animal out of 5 was considered as a negative one (4/5 Table 2). As discussed,
the SIT is severely compromised in respect of specificity following PTB vaccination, and there-
fore the observation that it detected all infected animals regardless of their vaccination status is
irrelevant (Table 2, VAC/INFEC and NVAC/INFEC groups, 10/10, Table 2). In marked con-
trast, the ability of the defined antigen reagents to detect M. bovis infected calves was not
Table 1. Percentage of positive animals for interferon-γ testing.
State Antigen W0 W4 W12 W18 W20 W22 W26 W30
VAC/NIN B-A 0% 0% 0% 0% 0% 20% 40% 20%
Rv3615c 0% 0% 0% 0% 20% 100% 20% 0%
ESAT-6/CFP10 0% 0% 0% 0% 0% 60% 20% 0%
VAC/INFEC B-A 0% 0% 0% 0% 100% 40% 40% 80%
Rv3615c 0% 0% 0% 0% 0% 80% 100% 80%
ESAT-6/CFP10 0% 0% 0% 0% 80% 100% 100% 100%
NVAC/INFEC B-A 0% 0% 0% 0% 100% 100% 100% 100%
Rv3615c 0% 0% 0% 0% 80% 100% 100% 100%
ESAT-6/CFP10 0% 0% 0% 0% 100% 100% 100% 100%
VAC/NIN: vaccinated non-infected group. VAC/INFEC: vaccinated infected group. NVAC/INFEC: non-vaccinated infected group. W: week. The Optical
Density (OD) cut-off for Rv3615 –PBS is >0.1 and > 0.3 for ESAT-6/CFP10—PBS. For the standard antigens the meet requirements are B-PPD > A-PPD
and OD for B-PPD—PBS is > 0.1. Vaccination was performed at W0 and experimental challenge at W18.
doi:10.1371/journal.pone.0169735.t001
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affected by their vaccination status, as 10/10 animals in the VAC/INFEC and NVAC/INF
groups were detected by protein and peptide cocktails (Table 2).
Table 3 shows the relative increase of the skin thickness 72h after the intradermal inocula-
tion. The VAC/INFEC group showed the greatest (Mean = 230%) relative skin increase to the
B-PPD followed by the NVAC/INFEC while the VAC/NIN group exhibited the smallest
(Mean = 63.8%) skin relative increase with the B-PPD. The A-PPD showed the greatest skin
increase in the vaccinated groups (VAC/INFEC (Mean = 127.4%) and VAC/NIN
(Mean = 128.6%)). Both, peptide and protein cocktails showed highest skin increase percent-
ages in the infected groups, (VAC/INFEC: Mean = 87.6% and Mean = 101%; NVAC/INFEC:
Mean = 92.6%; and Mean = 86.4% respectively) (Table 3).
Table 4 shows the performance of the different alternative diagnostic criteria. A SIT inter-
pretation with an absolute skin thickness increase of 6 mm or more detected all the VAC/
INFEC animals but none of the VAC/NIN, accounting for 100% Se and Sp.
With a comparative interpretation where an increase of 6 mm in the B-PPD that was equal
to or greater than the A-PPD, all VAC/NIN were correctly classified as negative, but only 3/5
of the VAC/INFEC were scored as positive. Thus the Se was 60% and the Sp 100%.
In order to establish criteria, focus was set on the vaccinated groups because the aim of this
work was to set up the parameters to be able to differentiate VAC/INFEC animals from those
which were only PTB-vaccinated. Regarding relative readings, for the SIT, a cut-off at a 100%
skin increase classified all the animals in the VAC/INFEC as bTB positive, while all in the
VAC/NIN group were classified as non-bTB reactors (Table 3). This yielded 100% Se and
100% Sp (Table 4). A comparative reading, scoring as positive a B-PPD relative increase
greater than the A-PPD increase, also yielded 100% Se and Sp. Using the protein cocktail two
Table 2. Intradermal Response: raw data and interpretation.
Interpretation ESAT-6/CFP10/Rv3615c cocktail
(Δmm interpretation)
State Calf Avian PPD (Δmm) Bovine PPD (Δmm) SIT CIT Peptide Protein
VAC/NIN 1 12 5 + N 0 N 0 N
2 14 5 + N 3 + 0 N
3 9 3 N N 1 N 0 N
4 6 4 + N 0 N 0 N
5 8 3 N N 0 N 0 N
VAC/INFEC 6 9 9 + N 3 + 5 +
7 7 6 + N 6 + 4 +
8 12 23 + + 11 + 15 +
9 11 10 + N 6 + 3 +
10 8 18 + + 7 + 7 +
NVAC/INFEC 11 2 9 + + 5 + 6 +
12 1 8 + + 8 + 6 +
13 1 12 + + 9 + 7 +
14 0 9 + + 3 + 3 +
15 1 5 + N 4 + 6 +
VAC/NIN: vaccinated non infected group. NVAC/INFEC: non vaccinated infected group. VAC/INFEC: vaccinated infected group. PPD: protein purified
derivative. SIT: single intradermal test, CIT: comparative intradermal test. N: negative. +: positive. Δmm: skin thickness increase in mm. The SIT is
considered positive when an increase bigger than 4mm is observed in the PPD-B injection site after 72h The CIT is considered positive when the skin
thickness increase at the PPD-B injection site is 4 mm greater than the increase induced at the PPD-A injection site after 72h. A ESAT-6/CFP10/Rv3615c
peptide or protein cocktail result will be considered positive if the skin thickness increase is equal to or bigger than 2mm.
doi:10.1371/journal.pone.0169735.t002
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Table 3. Individual skin test results: skin thickness increase relative to the initial reading.
ESAT-6/CFP10/Rv3615c
Avian PPD Bovine PPD Peptide cocktail Protein cocktail
State Calf Δ% Δ% Δ% Δ%
VAC/NIN 1 120 63 0 0
2 140 56 30 0
3 150 60 17 0
4 100 80 0 0
5 133 60 0 0
MV = 128,6 63,8 9,4 0
VAC/INFEC 6 150 150 43 71
7 140 150 120 100
8 109 383 100 167
9 138 167 75 50
10 100 300 100 117
MV = 127,4 230 87,6 101
NVAC/INFEC 11 33 180 83 120
12 13 133 133 100
13 13 171 180 88
14 0 113 27 38
15 17 62 40 86
MV = 15,2 131,8 92,6 86,4
VAC/NIN: vaccinated non infected group. NVAC/INFEC: non vaccinated infected group. VAC/INFEC: vaccinated infected group. Δ%: skin thickness
increase at 72 h after inoculation expressed as a percentage. MV: mean value
doi:10.1371/journal.pone.0169735.t003
Table 4. Skin thickness interpretation criteria after application of the different antigens in the skin test.
Antigen Test type and interpretation Cut-off positivity criteria Sensitivity % Specificity %
Official diagnostic criteria: vaccinated and non-vaccinated animals
PPD Single official Standard: Δmm B-PPD4 100 40
Strict: Δmm B-PPD>2 100 0
Comparative official Standard: Δmm B-PPD4 and >A-PPD 70 100
Strict: Δmm B-PPD>2 and >A-PPD 70 100
Alternative diagnostic criteria (vaccinated animals only)
PPD Single absolute Δmm 6 100 100
Comparative absolute Δmm 6 and B-PPD A-PPD 60 100
Single relative  100% 100 100
Comparative relative  100% and B-PPD A-PPD 100 100
Peptide cocktail Single absolute Δmm 3 100 80
Single relative  40% 100 100
Protein cocktail Single absolute Δmm 3 100 100
Single relative  30% 100 100
Alternative diagnostic criteria (non-vaccinated animals only)
Peptide cocktail Single absolute Δmm 3 100 100
Protein cocktail Single absolute Δmm 3 100 100
A-PPD: avian purified protein derivative. B-PPD: bovine purified protein derivative.
doi:10.1371/journal.pone.0169735.t004
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different cut-offs were established. The first one takes into account the absolute skin increase
and the second the relative. Despite the low number of animals belonging to each group, these
results are very interesting since all the animals were correctly classified.
Discussion
The main aim of this study was to assess the interference of an inactivated PTB vaccine with
the official bTB diagnostic tests. In order to improve the diagnostic efficacy of the CMI-based
test, the immunological response of the animals was determined comparing the standard anti-
gens PPD-A and PPD-B with two different formulations of defined antigens (ESAT-6/CFP10
and Rv3615c) [29]. In addition, new criteria for result interpretation according to the vaccina-
tion status of animals were explored.
During the last decade great efforts have been dedicated to the study and development of
new specific antigens [29,30] that have been thoroughly assessed by in vitro IFN-gamma tests
[31]. The use of these antigens has received attention for the skin test [32] in PTB vaccinated
animals, and it has been proven that protein [23,32] and peptidic cocktails [31] can be suitable
under field conditions.
Furthermore, to the best of our knowledge, this is the first time that the skin test has been
performed with these specific cocktails in PTB vaccinated animals and subsequently M. bovis
infected cattle, although these antigens had been previously shown not to be recognized fol-
lowing PTB vaccination in goats [33]. (Jones et al., CVI 2012).
The M. bovis challenge process was carried out successfully; all the calves belonging to
infected groups became infected regardless of their vaccination status. However, the severity
and extension of the lesions was lower in the VAC/INFEC animals (data not shown). These
results are in agreement with the findings from Pérez del Val et al [33] who also reported that
Map vaccinated and M. bovis infected goats showed minor severity and extension of the lesions
in an experimental setting, suggesting that PTB vaccination could provide a certain degree of
containment of bTB dissemination [33].
The dynamics of the IFN-gamma test results shows that PTB vaccination induced a
response against standard PPD mycobacterial antigens that was predominantly of the avian
type before to M. bovis challenge. Although a noticeable degree of cross reactivity to B-PPD
was observed it did not affect the Sp of the CIT. After infection, all groups switched to a pre-
dominantly bovine PPD-biased response that was slightly lower in the vaccinated group com-
pared to the non-vaccinated group. All the animals belonging to the VAC/INFEC group were
categorized as infected only in the first sampling post-challenge at W20, while all NVAC/
INFEC animals were positive throughout the complete post-infection period. This indicates
that IFN-gamma test did not work well in vaccinated animals in terms of Se and also Sp.
The more specific antigens worked better in terms of Se, in particular ESAT-6/CFP10 that
only failed to detect one animal on W20, two weeks post challenge. It was also the most specific
since it only yielded false positive results in the non-infected group for two animals four weeks
post-infection (W22) and for one calf eight weeks post-infection (W26). The movement of the
animals to the P3 facilities might have changed the microbial environment and induced an
unspecific cellular immune response that reached a certain development in the VAC/NIN
group, but that was quickly replaced by a more specific one in the animals that were challenged
with M. bovis.
Results have demonstrated that the response pattern of the traditional antigens versus the
more specific ones can be very different. The ESAT-6/CFP10 and Rv3615 antigens did not
show any kind of response during the post-vaccination period and they just underwent a raise
in their response after M. bovis challenge. A-PPD and B-PPD responses based on the IFN-
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gamma release made differentiation difficult especially among the VAC/INFEC animals. Simi-
lar results have been observed with the same antigens in goats [33].
In this experiment we decided to apply 2 interpretation criteria for the qualitative IFN-
gamma results: one for the B-PPD and a second one for the specific antigens responses. The
most extended OD cut-off point (0.1) was selected for the B-PPD. For the ESAT-6/CFP10 the
OD cut-off was set at 0.3 and at 0.1 for Rv3615c. Selecting these cut-offs, the Se of the tech-
nique in the most problematic group (VAC/INFEC) reached 100% when the ESAT-6/CFP10
antigen was used. This Se rate was maintained from the second post-infection sampling
throughout the experiment. Our data showed that the Se obtained with this specific antigen
was higher than the one obtained with B-PPD as previous researchers demonstrated [23,34].
Regarding the conventional CIT results, all the animals belonging to the VAC/NIN and
NVAC/INFEC groups were correctly classified in relation to the infectious status according to
treatment and necropsy results. The interference problem arose when the VAC/INFEC group
has to be diagnosed using the same criteria. Applying the traditional comparative skin test
60% of the VAC/INFEC animals were misclassified as M. bovis non-infected.
If new cut-off points were set up, this drawback could be overcome. Regarding the vacci-
nated and non-vaccinated groups alternative cut-offs were established for every antigen stud-
ied (Table 4). As it can be observed, from all the assessed possibilities, those which measured
the relative increase of the skin thickness were the most reliable in both vaccinated groups, in
terms of Se and Sp.
When the non-vaccinated animals were taken into account, whether the chosen diagnostic
interpretation is the official criterion or the new criterion, 100% of the animals were diagnosed
correctly in relation to our gold standard: the necropsy results. These outcomes reinforce the
idea that our efforts should focus on validating a technique able to identify all the animals
from the problematic group, VAC/INFEC animals.
In spite of the low number of animals and that they were kept under experimental condi-
tions, the Se and Sp obtained (100% respectively) when using the protein cocktail in the skin
test were very encouraging. All the animals belonging to the three different groups were cor-
rectly classified. That is why in view of the outstanding results it would be of great interest to
test the protein cocktail under field conditions.
In this experimental scheme, we have demonstrated that it is possible to differentiate M.
bovis infected animals even after PTB vaccination by including the specific antigens into the
skin test, or by adopting new interpretation criteria for the conventional ones. These findings
lend support to the PTB vaccination strategies showing that vaccination in bTB affected envi-
ronments should not be a problem.
Conclusions
Our results prove that the ESAT-6/CFP10 and Rv3615c proteinic and peptidic cocktails can be
used as skin test reagents in the face of PTB vaccination and M. bovis infection without
compromising either Se or Sp. In respect to IFN-gamma results, use of these defined antigens
improved the Se and Sp compared to the conventional antigens A-PPD and B-PPD. In conclu-
sion PTB vaccination produces interference in cattle experimentally infected with M. bovis,
but this could be overcome if new testing strategies such as new specific antigens were applied
alternative to or complementing the official bTB diagnostic tests or if new diagnostic criteria
with traditional antigens were established. Although the results presented are promising, this
study has been performed in experimental bTB infection conditions and they should be fur-
ther validated in field conditions.
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4. Carta T, Álvarez J, Pérez de la Lastra JM, Gortázar C. Wildlife and paratuberculosis: a review.
Research in veterinary science. Elsevier Ltd; 2013; 94: 191–7.
5. Harris NB, Barletta RG. Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine. Clinical
microbiology reviews. 2001; 14: 489–512. doi: 10.1128/CMR.14.3.489-512.2001 PMID: 11432810
6. Waters WR, Palmer M V., Buddle BM, Vordermeier HM. Bovine tuberculosis vaccine research: Histori-
cal perspectives and recent advances. Vaccine. Elsevier Ltd; 2012; 30: 2611–2622.
7. Müller B, Dürr S, Alonso S, Hattendorf J, Laisse CJM, Parsons SDC, et al. Zoonotic Mycobacterium
bovis–induced Tuberculosis in Humans. Emerging Infectious Diseases. 2013; 19: 899–908. doi: 10.
3201/eid1906.120543 PMID: 23735540
8. Rodwell TC, Kapasi AJ, Moore M, Milian-Suazo F, Harris B, Guerrero LP, et al. Tracing the origins of
Mycobacterium bovis tuberculosis in humans in the USA to cattle in Mexico using spoligotyping. Inter-
national Journal of Infectious Diseases. International Society for Infectious Diseases; 2010; 14: e129–
e135.
New Bovine Tuberculosis Diagnostic Criteria
PLOS ONE | DOI:10.1371/journal.pone.0169735 January 10, 2017 11 / 13
9. Chiodini RJ, Van Kruiningen HJ, Thayer WR, Coutu JA, Merkal RS. In vitro antimicrobial susceptibility
of a Mycobacterium sp. isolated from patients with Crohn’s disease. Antimicrob Agents Chemother.
1984; 26: 930–932. Available: http://www.ncbi.nlm.nih.gov/pubmed/6524906 PMID: 6524906
10. Elguezabal N, Chamorro S, Molina E, Garrido JM, Izeta A, Rodrigo L, et al. Lactase persistence, NOD2
status and Mycobacterium avium subsp. paratuberculosis infection associations to Inflammatory Bowel
Disease. Gut Pathogens. 2012; 4: 6. doi: 10.1186/1757-4749-4-6 PMID: 22742424
11. Juste RA, Elguezabal N, Pavón A, Garrido JM, Geijo M, Sevilla I, et al. Association between Mycobacte-
rium avium subsp. paratuberculosis DNA in blood and cellular and humoral immune response in inflam-
matory bowel disease patients and controls. International Journal of Infectious Diseases. 2009; 13:
247–254. doi: 10.1016/j.ijid.2008.06.034 PMID: 18922720
12. Naser S a, Ghobrial G, Romero C, Valentine JF. Culture of Mycobacterium avium subspecies paratu-
berculosis from the blood of patients with Crohn ‘ s disease. 2004; 28: 1039–1044.
13. Buddle BM, De Lisle GW, Pfeffer A, Aldwell FE. Immunological responses and protection against Myco-
bacterium bovis in calves vaccinated with a low dose of BCG. Vaccine. 1995; 13: 1123–1130. PMID:
7491820
14. Hasonova L, Pavlik I. Economic impact of paratuberculosis in dairy cattle herds: A review. Veterinarni
Medicina. 2006; 51: 193–211.
15. Juste RA, Perez V. Control of paratuberculosis in sheep and goats. The Veterinary clinics of North
America Food animal practice. 2011; 27: 127–38. doi: 10.1016/j.cvfa.2010.10.020 PMID: 21215897
16. Juste RA, Alonso-Hearn M, Molina E, Geijo M, Vazquez P, Sevilla IA, et al. Significant reduction in bac-
terial shedding and improvement in milk production in dairy farms after the use of a new inactivated
paratuberculosis vaccine in a field trial. BMC research notes. 2009; 2: 233. doi: 10.1186/1756-0500-2-
233 PMID: 19930604
17. Garrido JM, Vazquez P, Molina E, Plazaola JM, Sevilla IA, Geijo M V., et al. Paratuberculosis vaccina-
tion causes only limited cross-reactivity in the skin test for diagnosis of bovine tuberculosis. PLoS ONE.
2013; 8: 2–8.
18. Food E, Authority S, Centre E. Trends and sources of zoonoses, zoonotic agents and food-borne.
2015; 13.
19. Ministerio de agricultura alimentación y medio ambiente. Programa Nacional de erradicación de tuber-
culosis bovina presentado por España para el año 2014. 2014; 0–66.
20. Alonso-Hearn M, Molina E, Geijo M, Vazquez P, Sevilla IA, Garrido JM, et al. Immunization of adult
dairy cattle with a new heat-killed vaccine is associated with longer productive life prior to cows being
sent to slaughter with suspected paratuberculosis. Journal of dairy science. Elsevier; 2012; 95: 618–29.
21. Seva J, Sanes JM, Ramis G, Mas A, Quereda JJ, Villarreal-Ramos B, et al. Evaluation of the single cer-
vical skin test and interferon gamma responses to detect Mycobacterium bovis infected cattle in a herd
co-infected with Mycobacterium avium subsp. paratuberculosis. Veterinary Microbiology. Elsevier B.V.;
2014; 171: 139–146.
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